Oncology

Canada could be overpaying hundreds of millions, expert suggests.

New immunotherapy combinations improve clinical outcomes for non-small cell lung cancer.

Review of guidelines is ‘a call to action.’

Lung cancer is the most commonly diagnosed and deadliest, shows data collected over 25 years.

A recent study found the drug combination lenalidomide + rituximab is a durable, effective and safe alternative to the standard regimen combining rituximab and chemotherapy.

The treatment is approved for patients who have a moderate to high risk of recurrence, following nephrectomy or nephrectomy accompanied by surgical resection of metastatic lesions.

How much do you know about the impact of longer wait times for breast cancer screening and treatment?

This is a 34-yr-old male with a history of scalp lumps. But what is causing them?